Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
The Safety and Effects of Bosentan in Patients with a Fontan Circulation.
Sarah Bowater
, RA Weaver
, SA Thorne
,
Paul Clift
Birmingham Medical School
Research output
:
Contribution to journal
›
Article
27
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Safety and Effects of Bosentan in Patients with a Fontan Circulation.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fontan Circulation
100%
Bosentan
100%
Adverse Events
50%
New York Heart Association Functional Classification
50%
Ventricular Function
25%
Fontan Patients
25%
Classification Function
25%
Number of Patients
12%
Single Center
12%
Cardiovascular Function
12%
Patient Demographics
12%
Referral Center
12%
Blood Test
12%
Exercise Capacity
12%
Function Parameters
12%
Adult Patients
12%
Clinically Significant
12%
Tolerability
12%
18 Years Old
12%
Cardiopulmonary Exercise Testing
12%
Transthoracic Echocardiography
12%
Adult Congenital Heart Disease
12%
Endothelin Receptor Antagonist
12%
Dyspnea Score
12%
Safety Study
12%
Systolic Ventricular Function
12%
Hepatic Function Tests
12%
6-minute Walk Distance Test
12%
Pilot Safety
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bosentan
100%
Adverse Event
50%
Dyspnea
12%
Tolerability
12%
Congenital Heart Disease
12%
Endothelin Receptor Antagonist
12%